Literature DB >> 21604005

Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status.

Roy Moncayo, Annette Traeger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21604005     DOI： 10.1007/s00259-011-1839-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  10 in total

1.  The effects of exposure of 60Co on the oxidant/antioxidant status among radiation victims.

Authors:  Mustafa Demir; Dildar Konukoğlu; Levent Kabasakal; Hakan Kadir Yelke; Kadir Ergen; Sabbir Ahmed
Journal:  J Environ Radioact       Date:  2003       Impact factor: 2.674

2.  Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney?

Authors:  R Moncayo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10       Impact factor: 9.236

3.  The effects of 201Tl myocardial perfusion scintigraphy studies on oxidative damage in patients.

Authors:  E Cicek; M Yildiz; N Delibas; S Bahçeli
Journal:  West Indian Med J       Date:  2009-01       Impact factor: 0.171

Review 4.  Diagnosis and therapy are walking together on radiopeptides' avenue.

Authors:  Luigi Mansi; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04       Impact factor: 9.236

5.  The effects of thyroid scintigraphy studies on oxidative damage in patients.

Authors:  E Ciçek; M Yildiz; N Delibaş; S Bahçeli
Journal:  Acta Physiol Hung       Date:  2006-06

Review 6.  The human selenoproteome: recent insights into functions and regulation.

Authors:  M A Reeves; P R Hoffmann
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

7.  Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells.

Authors:  Gary E Olson; Virginia P Winfrey; Kristina E Hill; Raymond F Burk
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

8.  Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.

Authors:  Kim W Last; Victoria Cornelius; Trevor Delves; Christine Sieniawska; Jude Fitzgibbon; Andrew Norton; John Amess; Andy Wilson; Ama Z S Rohatiner; T Andrew Lister
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

9.  Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice.

Authors:  Erik Vegt; Marleen Melis; Annemarie Eek; Monique de Visser; Maarten Brom; Wim J G Oyen; Martin Gotthardt; Marion de Jong; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-18       Impact factor: 9.236

10.  The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma.

Authors:  Roy Moncayo; Alexander Kroiss; Manfred Oberwinkler; Fatih Karakolcu; Matthias Starzinger; Klaus Kapelari; Heribert Talasz; Helga Moncayo
Journal:  BMC Endocr Disord       Date:  2008-01-25       Impact factor: 2.763
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.